PCIA
AMGN icon

Prime Capital Investment Advisors’s Amgen AMGN Stock Holding History

Prime Capital Investment Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$50 – 1034
2025
Q2 		$50 Hold
100
– – ﹤0.01% 960
2025
Q1 		$700 Buy
+100
New +$29.5K ﹤0.01% 1065

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Prime Capital Investment Advisors's AMGN Position: Q1 2026 in Review

Prime Capital Investment Advisors reduced its Amgen (AMGN) stake by 9.3% in Q1 2026, selling an estimated $640K and leaving 17,523 shares worth $6.17M. The position accounts for 0.07% of the portfolio, ranked #198.

Prime Capital Investment Advisors first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. The position peaked at $15.6M in Q3 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Prime Capital Investment Advisors held 17,523 shares of Amgen worth $6.17M as of Q1 2026.
  • Prime Capital Investment Advisors sold 1,795 Amgen shares in Q1 2026, an estimated $640K.
  • Amgen made up 0.07% of Prime Capital Investment Advisors's portfolio in Q1 2026, its #198 holding.
  • Prime Capital Investment Advisors first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
  • Prime Capital Investment Advisors's Amgen position peaked at $15.6M in Q3 2024.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.